| Literature DB >> 26224645 |
Julien Record1, Dessislava Malinova1, Helen L Zenner2, Vincent Plagnol3, Karolin Nowak1, Farhatullah Syed1, Gerben Bouma1, James Curtis2, Kimberly Gilmour4, Catherine Cale4, Scott Hackett5, Guillaume Charras6, Dale Moulding1, Sergey Nejentsev2, Adrian J Thrasher7, Siobhan O Burns8.
Abstract
Megakaryoblastic leukemia 1 (MKL1), also known as MAL or myocardin-related transcription factor A (MRTF-A), is a coactivator of serum response factor, which regulates transcription of actin and actin cytoskeleton-related genes. MKL1 is known to be important for megakaryocyte differentiation and function in mice, but its role in immune cells is unexplored. Here we report a patient with a homozygous nonsense mutation in the MKL1 gene resulting in immunodeficiency characterized predominantly by susceptibility to severe bacterial infection. We show that loss of MKL1 protein expression causes a dramatic loss of filamentous actin (F-actin) content in lymphoid and myeloid lineage immune cells and widespread cytoskeletal dysfunction. MKL1-deficient neutrophils displayed reduced phagocytosis and almost complete abrogation of migration in vitro. Similarly, primary dendritic cells were unable to spread normally or to form podosomes. Silencing of MKL1 in myeloid cell lines revealed that F-actin assembly was abrogated through reduction of globular actin (G-actin) levels and disturbed expression of multiple actin-regulating genes. Impaired migration of these cells was associated with failure of uropod retraction likely due to altered contractility and adhesion, evidenced by reduced expression of the myosin light chain 9 (MYL9) component of myosin II complex and overexpression of CD11b integrin. Together, our results show that MKL1 is a nonredundant regulator of cytoskeleton-associated functions in immune cells and fibroblasts and that its depletion underlies a novel human primary immunodeficiency.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26224645 PMCID: PMC4671330 DOI: 10.1182/blood-2014-12-611012
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113